Safety and costs of initiating angiotensin converting enzyme inhibitors for heart failure in primary care: analysis of individual patient data from studies of left ventricular dysfunction.
about
Secondary prevention following myocardial infarction: evidence from an audit in South Wales that the National Service Framework for coronary heart disease does not address all the issuesUndertreatment of heart failure has high cost to patients.Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation.Taking heart failure seriously.Use of calcium antagonists and worsening renal function in patients receiving angiotensin-converting-enzyme inhibitors.Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice.
P2860
Safety and costs of initiating angiotensin converting enzyme inhibitors for heart failure in primary care: analysis of individual patient data from studies of left ventricular dysfunction.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Safety and costs of initiating ...... left ventricular dysfunction.
@ast
Safety and costs of initiating ...... left ventricular dysfunction.
@en
type
label
Safety and costs of initiating ...... left ventricular dysfunction.
@ast
Safety and costs of initiating ...... left ventricular dysfunction.
@en
prefLabel
Safety and costs of initiating ...... left ventricular dysfunction.
@ast
Safety and costs of initiating ...... left ventricular dysfunction.
@en
P2093
P2860
P1433
P1476
Safety and costs of initiating ...... left ventricular dysfunction.
@en
P2093
P2860
P304
P356
10.1136/BMJ.321.7269.1113
P407
P577
2000-11-01T00:00:00Z